NCT05098171View on ClinicalTrials.gov

Study on Signal Switch Receptor Modified TIL for the Treatment of Advanced Gynecologic Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 26, 2021

Primary Completion Date

September 25, 2025

Study Completion Date

September 25, 2026

Conditions
Advanced Gynecologic TumorsSignal Switch Receptor Modified TILTreatment Side EffectsEffects of Immunotherapy
Interventions
BIOLOGICAL

Signal Switch Receptor Modified TIL

Adoptive transfer of 2x10\^8-1x10\^10 autologous signal switch receptor modified TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

200000

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai 10th People's Hospital

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY